.
MergerLinks Header Logo

New Deal


Announced

Completed

Apotex to acquire Arrow Pharmaceuticals from Strides Pharma Science.

Financials

Edit Data
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

genetic products

manufacturing

drugs

Pharmaceuticals

Australia

Private

Merger

Natural

Completed

Single Bidder

Synopsis

Edit

Apotex, a Canadian pharmaceutical corporation, to acquire Arrow Pharmaceuticals, the Australian operating business of Strides, held through Singapore, Apotex, a Canadian pharmaceutical corporation, from Strides Pharma Science, an Indian pharmaceutical company. "The strong relationships we have built with our much-valued pharmacy customers to date will be fundamental to our joint success. Importantly, the proposed merger will also provide Australian pharmacists, their patients and consumers alike with ongoing access to a diverse range of almost 500 low-cost medicines, and permit the expansion of our current product ranges, including OTC, vitamins and practitioner-only products," Apotex Managing Director, Asia Pacific, Roger Millichamp.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US